Trop2 Promotes Multidrug Resistance by Regulating Notch1 Signaling Pathway in Gastric Cancer Cells

Overview

Journal Med Sci Monit

Specialties General Medicine
Pathology

Date 2020 Jan 23

PMID 31964857

Citations 11

Authors

Xingwang Kuai

Lizhou Jia

Tingting Yang

Xiaochen Huang

Wei Zhao

Mingjiong Zhang

Yuan Chen

Jin Zhu

Zhenqing Feng

Qi Tang

Affiliations

Soon will be listed here.

Abstract

BACKGROUND Chemotherapy is widely used in gastric cancer treatment, but multidrug resistance remains a leading cause of chemotherapy failure. Trop2 is highly expressed in gastric tumor tissues and greatly influences cancer progression. However, little is known about the relationship between Trop2 and drug resistance in gastric cancer. MATERIAL AND METHODS In the present study, Trop2 was knocked down in BGC823 cells and overexpressed in HGC27. CCK-8 assay was performed to explore the relationship of Trop2 expression and cell proliferation treated with anticancer drugs. Flow cytometry was performed to assess the relationship between Trop2 and cell apoptosis after chemotherapy. Subcutaneous xenograft models were generated to explore the curative effect of DDP to GC in vivo. MRP1 and Notch1 expressions were assessed by Western blot. RESULTS Trop2 decreased cell proliferation inhibition and apoptosis after chemotherapeutic treatments. DDP showed stronger therapeutic effects on Trop2-knockdown tumor than control in vivo. MRP1 and Notch1 signaling pathway were confirmed to participate in Trop2-induced drug resistance. CONCLUSIONS Our findings suggest that Trop2 promotes the resistance of gastric cancer to chemotherapy by activating the Notch1 pathway.

Citing Articles

Identification of TACSTD2 as novel therapeutic targets for cisplatin-induced acute kidney injury by multi-omics data integration.

Deng Z, Dong Z, Wang Y, Dai Y, Liu J, Deng F Hum Genet. 2024; 143(9-10):1061-1080.

PMID: 38369676 DOI: 10.1007/s00439-024-02641-w.

The Relationship between Trop-2, Chemotherapeutic Drugs, and Chemoresistance.

Koltai T, Fliegel L Int J Mol Sci. 2024; 25(1).

PMID: 38203255 PMC: 10779383. DOI: 10.3390/ijms25010087.

An assembly of TROP2-mediated signaling events.

Upadhyay S, Devasahayam Arokia Balaya R, Parate S, Dagamajalu S, Keshava Prasad T, Shetty R J Cell Commun Signal. 2023; 17(3):1105-1111.

PMID: 37014471 PMC: 10409939. DOI: 10.1007/s12079-023-00742-1.

TROP2 is a Good Indicator for Infiltrative Nature of Carcinoma Rather than Diagnosing Malignancy in Thyroid.

Kilinc E, Gunes P, Doganer A Indian J Otolaryngol Head Neck Surg. 2022; 74(Suppl 2):2560-2568.

PMID: 36452626 PMC: 9702226. DOI: 10.1007/s12070-020-02275-0.

TROP2 Represents a Negative Prognostic Factor in Colorectal Adenocarcinoma and Its Expression Is Associated with Features of Epithelial-Mesenchymal Transition and Invasiveness.

Svec J, Stastna M, Janeckova L, Hrckulak D, Vojtechova M, Onhajzer J Cancers (Basel). 2022; 14(17).

PMID: 36077674 PMC: 9454662. DOI: 10.3390/cancers14174137.

References

Chen M, Wu H, Zhan Y, Fu X, Wang A, Wang L . Prognostic value of TROP2 expression in patients with gallbladder cancer. Tumour Biol. 2014; 35(11):11565-9. DOI: 10.1007/s13277-014-2469-9. View

Shvartsur A, Bonavida B . Trop2 and its overexpression in cancers: regulation and clinical/therapeutic implications. Genes Cancer. 2015; 6(3-4):84-105. PMC: 4426947. DOI: 10.18632/genesandcancer.40. View

Kartal-Yandim M, Adan-Gokbulut A, Baran Y . Molecular mechanisms of drug resistance and its reversal in cancer. Crit Rev Biotechnol. 2015; 36(4):716-26. DOI: 10.3109/07388551.2015.1015957. View

Lu C, He Y, Yuan W, Xiang L, Zhang J, Liang Y . Dihydromyricetin-mediated inhibition of the Notch1 pathway induces apoptosis in QGY7701 and HepG2 hepatoma cells. World J Gastroenterol. 2017; 23(34):6242-6251. PMC: 5603490. DOI: 10.3748/wjg.v23.i34.6242. View

Sun Y, Luo X, Yang K, Sun X, Li X, Zhang C . Neural overexpression of multidrug resistance-associated protein 1 and refractory epilepsy: a meta-analysis of nine studies. Int J Neurosci. 2015; 126(4):308-17. DOI: 10.3109/00207454.2015.1015724. View

Li X, Teng S, Zhang Y, Zhang W, Zhang X, Xu K . TROP2 promotes proliferation, migration and metastasis of gallbladder cancer cells by regulating PI3K/AKT pathway and inducing EMT. Oncotarget. 2017; 8(29):47052-47063. PMC: 5564543. DOI: 10.18632/oncotarget.16789. View

Upadhyay P, Nair S, Kaur E, Aich J, Dani P, Sethunath V . Notch pathway activation is essential for maintenance of stem-like cells in early tongue cancer. Oncotarget. 2016; 7(31):50437-50449. PMC: 5226594. DOI: 10.18632/oncotarget.10419. View

Ripani E, Sacchetti A, Corda D, Alberti S . Human Trop-2 is a tumor-associated calcium signal transducer. Int J Cancer. 1998; 76(5):671-6. DOI: 10.1002/(sici)1097-0215(19980529)76:5<671::aid-ijc10>3.0.co;2-7. View

Cubas R, Zhang S, Li M, Chen C, Yao Q . Trop2 expression contributes to tumor pathogenesis by activating the ERK MAPK pathway. Mol Cancer. 2010; 9:253. PMC: 2946292. DOI: 10.1186/1476-4598-9-253. View

10.

Van Cutsem E, Sagaert X, Topal B, Haustermans K, Prenen H . Gastric cancer. Lancet. 2016; 388(10060):2654-2664. DOI: 10.1016/S0140-6736(16)30354-3. View

11.

Lipinski M, Parks D, Rouse R, Herzenberg L . Human trophoblast cell-surface antigens defined by monoclonal antibodies. Proc Natl Acad Sci U S A. 1981; 78(8):5147-50. PMC: 320350. DOI: 10.1073/pnas.78.8.5147. View

12.

Zhong Y, Shen S, Zhou Y, Mao F, Lin Y, Guan J . NOTCH1 is a poor prognostic factor for breast cancer and is associated with breast cancer stem cells. Onco Targets Ther. 2016; 9:6865-6871. PMC: 5106235. DOI: 10.2147/OTT.S109606. View

13.

Jundt F, Anagnostopoulos I, Forster R, Mathas S, Stein H, Dorken B . Activated Notch1 signaling promotes tumor cell proliferation and survival in Hodgkin and anaplastic large cell lymphoma. Blood. 2002; 99(9):3398-403. DOI: 10.1182/blood.v99.9.3398. View

14.

Vaziri-Gohar A, Houston K . GPER1-mediated IGFBP-1 induction modulates IGF-1-dependent signaling in tamoxifen-treated breast cancer cells. Mol Cell Endocrinol. 2015; 422:160-171. PMC: 4742395. DOI: 10.1016/j.mce.2015.11.033. View

15.

Ye Q, Zhang Y, Peng X, Long Z, Ming Y, He L . Silencing Notch-1 induces apoptosis and increases the chemosensitivity of prostate cancer cells to docetaxel through Bcl-2 and Bax. Oncol Lett. 2012; 3(4):879-884. PMC: 3362393. DOI: 10.3892/ol.2012.572. View

16.

Liu C, Li Z, Bi L, Li K, Zhou B, Xu C . NOTCH1 signaling promotes chemoresistance via regulating ABCC1 expression in prostate cancer stem cells. Mol Cell Biochem. 2014; 393(1-2):265-70. DOI: 10.1007/s11010-014-2069-4. View

17.

Ayers G, McKinley E, Zhao P, Fritz J, Metry R, Deal B . Volume of preclinical xenograft tumors is more accurately assessed by ultrasound imaging than manual caliper measurements. J Ultrasound Med. 2010; 29(6):891-901. PMC: 2925269. DOI: 10.7863/jum.2010.29.6.891. View

18.

Cho S, Lu M, He X, Ee P, Bhat U, Schneider E . Notch1 regulates the expression of the multidrug resistance gene ABCC1/MRP1 in cultured cancer cells. Proc Natl Acad Sci U S A. 2011; 108(51):20778-83. PMC: 3251103. DOI: 10.1073/pnas.1019452108. View

19.

Vulsteke C, Lambrechts D, Dieudonne A, Hatse S, Brouwers B, Van Brussel T . Genetic variability in the multidrug resistance associated protein-1 (ABCC1/MRP1) predicts hematological toxicity in breast cancer patients receiving (neo-)adjuvant chemotherapy with 5-fluorouracil, epirubicin and cyclophosphamide (FEC). Ann Oncol. 2013; 24(6):1513-25. DOI: 10.1093/annonc/mdt008. View

20.

Lu J, Pokharel D, Bebawy M . MRP1 and its role in anticancer drug resistance. Drug Metab Rev. 2015; 47(4):406-19. DOI: 10.3109/03602532.2015.1105253. View